VEGFA and neoplasm: VEGF is one of the most predominant factors in tumor growth [9] and has an important role in the angiogenic pathway, which suggests that sustained VEGF inhibition by treatment through multiple lines (first- to second-line treatment) is essential for long-term disease control beyond progressive disease (PD) [10].